| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/07/2001 | CN1283110A Tablet for instant and prolonged release of one or more active substances |
| 02/07/2001 | CN1283109A Method for making a pharmaceutical formulation |
| 02/07/2001 | CN1283108A I (chlamydia) protein, gene sequence and uses thereof |
| 02/07/2001 | CN1283106A Pharmaceutical compositions comprising micelles comprising lipophilic glucoiorticosteroid and only one surfactant |
| 02/07/2001 | CN1283105A Water-soluble eye drop |
| 02/07/2001 | CN1283103A Low-PH, acid-containing personal care compositions which exhibit reduced sting |
| 02/07/2001 | CN1283083A Revitalisation formulation |
| 02/07/2001 | CN1282744A Preparation of furoic acid momisone |
| 02/07/2001 | CN1282743A New beta-carbiline compounds, their preparation method and medicine composition conterning same |
| 02/07/2001 | CN1282740A Intermediate compound for preparing xibo ketone |
| 02/07/2001 | CN1282738A Improved method for sgnthesizing 6,9-bis[(2-aminoethyl) amino] benz[g] isoquinoline-5, 10-diketone and its dimaleate |
| 02/07/2001 | CN1282737A Intermediate product used for preparing substituted quinoline-2-formamide |
| 02/07/2001 | CN1282612A Antituberculotic aerosol composition and its preparing process |
| 02/07/2001 | CN1282602A Antifatigue capsule |
| 02/07/2001 | CN1282585A Compound necleotide preparation |
| 02/07/2001 | CN1282584A Application of icariin in preventing and treating sexual disfunction and improving diseases associated with vasoconstriction |
| 02/07/2001 | CN1282583A Exterior-applied ointment |
| 02/07/2001 | CN1282582A Application of allopurinol for medical purpose |
| 02/07/2001 | CN1282581A Medicine composition |
| 02/07/2001 | CN1282580A Release-controlling coating of antineoplastic leurocristine |
| 02/07/2001 | CN1282579A Exterior-applied medicine for treating ephelides |
| 02/07/2001 | CN1282578A Release-controlling coating of antineoplastic lomustine |
| 02/07/2001 | CN1282577A Application of dimethyl sulfoxide in improving sensitivity of antibiotics to bacteria |
| 02/07/2001 | CN1061658C Tricyclic benzazepine vasopression antagonists |
| 02/07/2001 | CN1061656C Drocess for preparation of tetrazole derivatives in two crystalline forms and novel crystalline form of said derivative |
| 02/07/2001 | CN1061655C Method for preparing cycloheptimidazole derivatives |
| 02/07/2001 | CN1061654C Process for preparation of tetrazole derivatives |
| 02/07/2001 | CN1061653C Benzofuran compounds, process for their preparation and pharmaceutical compositions thereof |
| 02/07/2001 | CN1061652C Endotheliomycine receptor antagonist |
| 02/07/2001 | CN1061648C Antiarrhythmic and cardioprotective substituted indenoyiguanidines |
| 02/07/2001 | CN1061558C Ginkgo and calcium capsule |
| 02/07/2001 | CN1061546C Preparation for treating burns and empyrosis and its preparing process |
| 02/06/2001 | US6185453 Iontophoretic device including specified integrin inhibitors such as n3-(2-(3-(4-formamidinophenyl)-isoxazolin-5(r,s)-yl)-acetyl)-n2 -(phenylsulfonyl)-2,3-(s)-diaminopropanoic acid |
| 02/06/2001 | US6184422 Cyclohexanediol derivatives |
| 02/06/2001 | US6184397 Preparation of sterol and stanol-esters |
| 02/06/2001 | US6184393 Pyronin antibacterials, process and novel intermediates thereto |
| 02/06/2001 | US6184389 Feature a plurality of functional groups attached to backbone and phosphoramidate sites |
| 02/06/2001 | US6184382 Process for preparing N6-substituted adenosine derivatives |
| 02/06/2001 | US6184376 Potent antivirals, especially against herpes infections, such as those caused by varicella zoster virus, herpes simplex, epstein-barr virus, herpes type 6 (hhv-6) and type 8 (hhv-8). shingles in the elderly or chicken pox in the young |
| 02/06/2001 | US6184374 Targeted cytotoxic anthracycline analogs |
| 02/06/2001 | US6184371 Lactoferrin receptor genes of Moraxella |
| 02/06/2001 | US6184369 Anti-viral guanosine-rich oligonucleotides |
| 02/06/2001 | US6184366 Substituted liposaccharides useful in the treatment and prevention of endotoxemia |
| 02/06/2001 | US6184365 Anthracycline derivatives having 4-amino-2,4,6-trideoxy-2 fluoro-α-L-talopyranosyl group |
| 02/06/2001 | US6184363 Inhibitors of β-lactamases and uses therefor |
| 02/06/2001 | US6184352 Adseverin protein |
| 02/06/2001 | US6184256 Methods and compositions for use in modulating expression of matrix metalloproteinase genes |
| 02/06/2001 | US6184255 Enhanced absorption |
| 02/06/2001 | US6184254 Methods of identifying modulators of perivascular sensory nerve Ca2+ receptors |
| 02/06/2001 | US6184253 Remedy for autoimmune diseases |
| 02/06/2001 | US6184252 2-amino-1,3-alkanediol compositions for inducing/stimulating hair growth and/or retarding hair loss |
| 02/06/2001 | US6184251 Use of arachidonic acid and/or docosahexanoic acid for the treatment of dyspraxia |
| 02/06/2001 | US6184250 Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension |
| 02/06/2001 | US6184249 Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes |
| 02/06/2001 | US6184248 Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
| 02/06/2001 | US6184247 Method of increasing cell renewal rate |
| 02/06/2001 | US6184246 Inhibition of cytokine production by polymethoxylated flavones |
| 02/06/2001 | US6184244 C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/06/2001 | US6184243 Neurological disorders |
| 02/06/2001 | US6184241 Aspartic protease inhibitors |
| 02/06/2001 | US6184237 Substituted pyridine compounds and methods of use |
| 02/06/2001 | US6184236 Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative |
| 02/06/2001 | US6184235 2-phenyl benzimidazole derivatives as MCP-1 antagonists |
| 02/06/2001 | US6184233 Crystals having storage stability, oral absorption, solubility; hypotensive agents, platelet agglutination control agents |
| 02/06/2001 | US6184232 Amine adduct which competetively binds with target cell counterion and functions differently compared to natural intracellular polyamines; anticarcinogenic agents |
| 02/06/2001 | US6184231 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators |
| 02/06/2001 | US6184230 Administering orally a quinolone antibiotic comprising 1-hydroxy-2-(2-trans-nonenyl)-3-methyl-4(1h)-quinolone or salt to treat gastrointestinal disorders, lymphomas, chronic heart disease |
| 02/06/2001 | US6184229 For treatment of disorders associated with the disfunctioning of nicotinic receptors |
| 02/06/2001 | US6184228 Selecting from a library a set of hemoglobin-s (hbs) ligands which exhibit inhibition of hbs polymerization, then selecting a subset of ligands which inhibit red blood cell sickling |
| 02/06/2001 | US6184227 Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases |
| 02/06/2001 | US6184226 Antiinflammatory agents for treatment of cardiovascular system disorders/respiratory system disorders, antiischemic agents |
| 02/06/2001 | US6184224 Drug resistance and side effect reduction |
| 02/06/2001 | US6184223 Reverse-turn mimetics and methods relating thereto |
| 02/06/2001 | US6184222 Administering norepinephrine reuptake inhibitor selective for norepinephrine over other neurotransmitters; side effect reduction |
| 02/06/2001 | US6184221 Antiarrhythmia agents, antiulcer agents |
| 02/06/2001 | US6184220 Low viscosity acid enolcarboxamide non-steroidal antiinflammatory drug (nsaid) suspension stabilised by a low concentration of dispersed silica in the presence of a water soluble cellulose ether |
| 02/06/2001 | US6184219 Composition and methods employing it for the treatment of 5-HT-mediated disorders |
| 02/06/2001 | US6184218 Mixture of citalopram and (r)-3-n,n-dicyclobutylamino-8-fluoro-3,4-dihydro-2h-1-benzopyran-5 -carboxamide hydrogen (2r,3r)-tartrate monohydrate (nad-299); antidepressants |
| 02/06/2001 | US6184217 Administering antiinflammatory dosage of a ring-substituted indolocarbazole derivative compound; tumor necrosis factor (tnf) inhibitors |
| 02/06/2001 | US6184216 Effective both as antidiabetic agent and antiobesity agent |
| 02/06/2001 | US6184215 Treatment of skin conditions with oxysterol activators of LXRα |
| 02/06/2001 | US6184214 Hydrolysis of 2-dichlorophosphoryloxy-acrylonitrile to form 2-hydroxyacrylamide-o-monophosphate; antiischemic agents for treating disorders due to the lack of atp |
| 02/06/2001 | US6184211 Inhibition of DNA methyltransferase |
| 02/06/2001 | US6184209 Diabetes treatment |
| 02/06/2001 | US6184204 Peptides suitable for use in antigen specific immunosuppressive therapy |
| 02/06/2001 | US6184200 Truncated glial cell line-derived neurotrophic factor |
| 02/06/2001 | US6184199 Active synergetic complex and cosmetic and/or pharmaceutical product containing this complex |
| 02/06/2001 | US6184037 Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell |
| 02/06/2001 | US6184025 Nucleotide sequences for the detection and diagnosis of viral diseases |
| 02/06/2001 | US6184013 Antibody for reducing concentration of drug in patient |
| 02/06/2001 | US6184009 Process for the preparation of materials with a high content of conjugated long chain polyunsaturated fatty acids |
| 02/06/2001 | US6183993 Complement-resistant non-mammalian DNA viruses and uses thereof |
| 02/06/2001 | US6183991 Nucleotide and amino acid sequence; recombinant production of polypeptide; enhancing viability of cryopreserved sperm, sperm motility, and fertilization in assisted reproduction; contraceptives |
| 02/06/2001 | US6183785 Source of zinc, preferably zinc gluconate, and chlorhexidine. |
| 02/06/2001 | US6183780 May be used for the application of active substances whenever a certain lag-time before release is advantageous, such as in be the case of anti-asthmatics, anti-emetics, cardiotonics, vasodilators, anti-vertigo and anti-meniere. |
| 02/06/2001 | US6183776 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate |
| 02/06/2001 | US6183775 Buccal delivery system |
| 02/06/2001 | US6183771 Transdermal compositions containing levosimendan |
| 02/06/2001 | US6183769 Methods of enhancing reproductive performance of animals |
| 02/06/2001 | US6183766 Lipophilic skin moisturizing agent; degreasing agent selected from the group consisting of: silicones, wax materials, powders, fluorochemicals and mixtures thereof; optionally a thickener, a humectant, a perfume; and water. |